Frontlight ResearchEarly access
Trial site
Uni of Chi Medi Ctr Hema and Onco
- 4running trials
- 3closed trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Diffuse large B-cell lymphoma2 trials
- Follicular lymphoma2 trials
- Acute lymphoblastic leukaemia1 trial
- ANCA-associated vasculitis1 trial
- Chronic lymphocytic leukaemia1 trial
- Hodgkin lymphoma1 trial
- Immune thrombocytopenia (ITP)1 trial
- Mesothelioma1 trial
- Multiple myeloma1 trial
- Phase
- Phase 12 trials
- Phase 22 trials
- Phase 32 trials
- Phase 1/21 trial
- Status
- Active, not recruiting4 trials
- Completed2 trials
- Terminated1 trial
- Lead sponsor
- Novartis Pharmaceuticals7 trials
Running trials
Active, not recruiting
Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA
Active, not recruiting
Active, not recruiting
A Phase I Study of IAG933 in Patients With Advanced Mesothelioma and Other Solid Tumors
Active, not recruiting
Phase I/II Study of Rapcabtagene Autoleucel in CLL, 3L+ DLBCL, r/r ALL and 1L HR LBCL
Closed trials
Site data: ClinicalTrials.govUpdated 13 Nov 2026